Chlamydia vaccine (Johns Hopkins University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameChlamydia vaccine (Johns Hopkins University)
Drug Alias Nameanti-idiotype GLXA (Johns Hopkins)Chlamydia vaccine (Johns Hopkins)
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsChlamydia Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins Technology VenturesJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsChlamydia Infections

Other Information

ATC CodeN/A
Related LinksN/A